Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Appropriately aggregate holistic technologies via accurate expertise. Intrinsicly strategize worldwide initiatives and premium methodologies.

HBV001: Phase I study evaluating the safety and immunogenicity of the therapeutic vaccine ChAdOx1-HBV.

Cargill T. et al, (2023), JHEP reports : innovation in hepatology, 5

Identification of novel resistance associated substitutions for sofosbuvir in HCV genotype 3a

Smith D. et al, (2018), JOURNAL OF HEPATOLOGY, 68, S269 - S269

Pathophysiology of ischaemic heart disease

Pocock MO. et al, (2017), Current Opinion in HIV and AIDS, 12, 548 - 553

Darunavir-based dual therapy in HIV experienced patients

Sterrantino G. et al, (2014), Journal of the International AIDS Society, 17, 19782 - 19782

Darunavir-based dual therapy in HIV experienced patients.

Sterrantino G. et al, (2014), Journal of the International AIDS Society, 17

Load More